IDEXX Laboratories, Inc. (IDXX) Q3 2012 Earnings Results

IDEXX Labs Beats on EPS, Stock Down 1.38%

IDEXX Labs reported an EPS that exceeded expectations, indicating strong profitability. However, the stock fell by 1.38% following the earnings report, likely due to the lack of revenue information and guidance. Investors may be concerned about the absence of detailed financial metrics to assess future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.76	N/A	+4.54%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's performance. They emphasized their commitment to growth and innovation.

Management expressed satisfaction with the EPS performance despite not providing revenue details.

They highlighted ongoing investments in innovation and customer engagement.

IDEXX Labs Beats on EPS, Stock Down 1.38%

Key numbers

Management commentary

IDEXX Laboratories, Inc.

More earnings this week

IDEXX Labs Beats on EPS, Stock Down 1.38%

Key numbers

Management commentary